Prognostic Prediction and Risk Stratification of Transarterial Chemoembolization Combined with Targeted Therapy and Immunotherapy for Unresectable Hepatocellular Carcinoma: A Dual-Center Study
The developed prognostic model serves as a reliable and convenient tool to predict outcomes in patients with unresectable HCC undergoing triple therapy. It aids clinicians in making informed treatment decisions.
Authors
- Zhentao Yan (ORCID: https://orcid.org/0000-0002-6949-5131)
- Wendi Kang
- Hao Li (ORCID: https://orcid.org/0009-0005-4886-9666)
- Siyuan Weng (ORCID: https://orcid.org/0000-0001-6645-648X)
- Qinshu Lian (ORCID: https://orcid.org/0000-0001-9570-5000)
- Zhengqiang Yang
- Xuan Zhou (ORCID: https://orcid.org/0000-0002-3602-5870)
- Huafei Zhao (ORCID: https://orcid.org/0000-0003-2890-1612)
- Hang Li (ORCID: https://orcid.org/0009-0003-3947-1993)
Institutions
- Central South University (CN)
- Guiyang Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Affiliated Hospital of Guizhou Medical University (CN)
- First Hospital of China Medical University (CN)
- Third Xiangya Hospital (CN)
- Guangdong 999 Brain Hospital (CN)
- China Medical University (CN)
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2024-11-01
- DOI
- https://doi.org/10.2147/jhc.s487080
- Citations
- 4
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.48